Trial intelligence / Profile preview

Different doses of dexmedetomidine for conscious sedation during awake nasotracheal fiberoptic intubation

PACTR201712002863123Not yet recruiting

Sponsor
Faculty of Medicine, Aswan University
Start
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dexmedetomidine in None and procedural sedation and analgesia (PSA) (2 arms), sponsored by Faculty of Medicine, Aswan University. Primary endpoints: Observer's Assessment of Alertness and Sedation Scale and Level of discomfort during nasal fiberoptic intubation. Planned start Jan 2018; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

procedural sedation and analgesia (PSA)

Beyond the preview

Go deeper on PACTR201712002863123.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201712002863123.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call